{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T14:29:49Z","timestamp":1648823389735},"reference-count":25,"publisher":"Sociedad Espanola de Patologia Digestiva (SEPD)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev Esp Enferm Dig"],"published-print":{"date-parts":[[2020]]},"DOI":"10.17235\/reed.2020.7217\/2020","type":"journal-article","created":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T08:33:57Z","timestamp":1600158837000},"source":"Crossref","is-referenced-by-count":1,"title":["New celiac disease biomarkers"],"prefix":"10.17235","volume":"112","author":[{"given":"Laura","family":"Rodr\u00edguez-Mart\u00edn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Vaquero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santiago","family":"Vivas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6910","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"[1]        Rubin JE, Crowe SE. Celiac disease. Ann Intern Med 2020;172:ITC1\ufffd16. https:\/\/doi.org\/10.7326\/AITC202001070.","DOI":"10.7326\/AITC202001070"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"[2]\tBurgue\u00f1o G\u00f3mez B, Escudero-Hern\u00e1ndez C, Rodrigo de P, et al. Duodenal lymphogram as a complementary tool in the diagnosis of celiac disease in adults.  Rev Esp Enf Dig 2020; https:\/\/doi.org\/10.17235\/reed.2020.6391\/2019. Online ahead of print.","DOI":"10.17235\/reed.2020.6391\/2019"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"[3]\tSadeghi A, Rad N, Ashtari S, et al.  The value of a biopsy in celiac disease follow up: Assessment of the small bowel after 6 and 24 months treatment with a gluten free diet. Rev Esp Enf Dig 2020; 112:101-108.  https:\/\/doi.org\/10.17235\/reed.2019.5947\/2018.","DOI":"10.17235\/reed.2019.5947\/2018"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"[4]        Strimbu K, Tavel JA. What are biomarkers? Curr Opin HIV AIDS 2010;5:463\ufffd6. https:\/\/doi.org\/10.1097\/COH.0b013e32833ed177.","DOI":"10.1097\/COH.0b013e32833ed177"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"[5]        Yu XB, Uhde M, Green PH, et al. Autoantibodies in the extraintestinal manifestations of celiac disease. Nutrients 2018;10. https:\/\/doi.org\/10.3390\/nu10081123.","DOI":"10.3390\/nu10081123"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"[6]        Choung RS, Khaleghi Rostamkolaei S, Ju JM, et al. Synthetic Neoepitopes of the Transglutaminase\ufffdDeamidated Gliadin Complex as Biomarkers for Diagnosing and Monitoring Celiac Disease. Gastroenterology 2019;156:582-591.e1. https:\/\/doi.org\/10.1053\/j.gastro.2018.10.025.","DOI":"10.1053\/j.gastro.2018.10.025"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"[7]        Picascia S, Mandile R, Auricchio R, et al. Gliadin-Specific T-cells mobilized in the peripheral blood of coeliac patients by short oral gluten challenge: Clinical applications. Nutrients 2015;7:10020\ufffd31. https:\/\/doi.org\/10.3390\/nu7125515.","DOI":"10.3390\/nu7125515"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"[8]        Adriaanse M, Leffler DA. Serum markers in the clinical management of celiac disease. Dig Dis 2015;33:236\ufffd43. https:\/\/doi.org\/10.1159\/000371405.","DOI":"10.1159\/000371405"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"[9]        Adriaanse MPM, Tack GJ, Passos VL, et al. Serum I-FABP as marker for enterocyte damage in coeliac disease and its relation to villous atrophy and circulating autoantibodies. Aliment Pharmacol Ther 2013;37:482\ufffd90. https:\/\/doi.org\/10.1111\/apt.12194.","DOI":"10.1111\/apt.12194"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"[10]        Vreugdenhil AC, Wolters VM, Adriaanse MP, et al. Additional value of serum I-FABP levels for evaluating celiac disease activity in children. Scand J Gastroenterol 2011;46:1435\ufffd41. https:\/\/doi.org\/10.3109\/00365521.2011.627447.","DOI":"10.3109\/00365521.2011.627447"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"[11]        Adriaanse MPM, Leffler DA, Kelly CP, et al. Serum I-FABP Detects Gluten Responsiveness in Adult Celiac Disease Patients on a Short-Term Gluten Challenge. Am J Gastroenterol 2016;111:1014\ufffd22. https:\/\/doi.org\/10.1038\/ajg.2016.162.","DOI":"10.1038\/ajg.2016.162"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"[12]       Rodr\u00edguez-Mart\u00edn L, Vaquero L, Vivas S. Serum I-FABP as marker for enterocyte damage in first-degree relatives of patients with coeliac disease. Aliment Pharmacol Ther 2015;42:121\ufffd2. https:\/\/doi.org\/10.1111\/apt.13187.","DOI":"10.1111\/apt.13187"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"[13]       Singh A, Pramanik A, Acharya P, et al. Non-Invasive Biomarkers for Celiac Disease. J Clin Med 2019;8:885. https:\/\/doi.org\/10.3390\/jcm8060885.","DOI":"10.3390\/jcm8060885"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"[14]       Fragkos KC, Forbes A. Citrulline as a marker of intestinal function and absorption in clinical settings: A systematic review and meta-analysis. United European Gastroenterol J 2018;6:181\ufffd91. https:\/\/doi.org\/10.1177\/2050640617737632.","DOI":"10.1177\/2050640617737632"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"[15]       Singh A, Verma AK, Das P, et al. Non-immunological biomarkers for assessment of villous abnormalities in patients with celiac disease. J Gastroenterol Hepatol 2020;35:438\ufffd45. https:\/\/doi.org\/10.1111\/jgh.14852.","DOI":"10.1111\/jgh.14852"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"[16]       Mor\u00f3n B, Verma AK, Das P, et al. CYP3A4-catalyzed simvastatin metabolism as a non-invasive marker of small intestinal health in celiac disease. Am J Gastroenterol 2013;108:1344\ufffd51. https:\/\/doi.org\/10.1038\/ajg.2013.151.","DOI":"10.1038\/ajg.2013.151"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"[17]       Manti S, Cuppari C, Tardino L, et al. HMGB1 as a new biomarker of celiac disease in children: A multicenter study. Nutrition 2017;37:18\ufffd21. https:\/\/doi.org\/10.1016\/j.nut.2016.12.011.","DOI":"10.1016\/j.nut.2016.12.011"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"[18]       Palone F, Vitali R, Trovato CM, et al. Faecal high mobility group box 1 in children with celiac disease: A pilot study. Dig Liv Dis 2018;50:916\ufffd9. https:\/\/doi.org\/10.1016\/j.dld.2018.04.003.","DOI":"10.1016\/j.dld.2018.04.003"},{"key":"ref19","unstructured":"[19]       Rashidiani S, Jalili A, Babaei E, et al. The chemokine CCL28 is elevated in the serum of patients with celiac disease and decreased after treatment. Am J Clin Exp Immunol 2017;6:60-65."},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"[20]       L\u00f3pez-Casado MA, Lorite P, Palomeque T, et al. Potential role of the IL-33\/ST2 axis in celiac disease. Cell Mol Immunol 2017;14:285-292.https:\/\/doi.org\/10.1038\/cmi.2015.85.","DOI":"10.1038\/cmi.2015.85"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"[21]       Pallone F, Monteleone Franz\u00e8 G, et al. Characterization of IL-17A\ufffdProducing Cells in Celiac Disease Mucosa. J Immunol 2010;184:2211\ufffd8. https:\/\/doi.org\/10.4049\/jimmunol.0901919.","DOI":"10.4049\/jimmunol.0901919"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"[22]       Yuksel M, Kaplan M, Ates I, et al. The role of soluble tumor necrosis factor like weak inducer of apoptosis and interleukin-17A in the etiopathogenesis of celiac disease. Medicine (Baltimore) 2016;95:e3937. https:\/\/doi.org\/10.1097\/MD.0000000000003937.","DOI":"10.1097\/MD.0000000000003937"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"[23]       Comino I, Real A, Vivas S, et al. Monitoring of gluten-free diet compliance in celiac patients by assessment of gliadin 33-mer equivalent epitopes in feces. Am J Clin Nutr 2012;95:670\ufffd7. https:\/\/doi.org\/10.3945\/ajcn.111.026708.","DOI":"10.3945\/ajcn.111.026708"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"[24]       Moreno ML, Cebolla A, Mu\u00f1oz-Suano A, et al. Detection of gluten immunogenic peptides in the urine of patients with coeliac disease reveals transgressions in the gluten-free diet and incomplete mucosal healing. Gut 2017;66:250\ufffd7. https:\/\/doi.org\/10.1136\/gutjnl-2015-310148.","DOI":"10.1136\/gutjnl-2015-310148"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"[25]       Comino I, Fern\u00e1ndez-Ba\u00f1ares F, Esteve M, et al. Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease Patients. Am J Gastroenterol 2016;111:1456\ufffd65. https:\/\/doi.org\/10.1038\/ajg.2016.439.","DOI":"10.1038\/ajg.2016.439"}],"container-title":["Revista Espa\u00f1ola de Enfermedades Digestivas"],"original-title":[],"deposited":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T08:34:01Z","timestamp":1600158841000},"score":1,"resource":{"primary":{"URL":"https:\/\/online.reed.es\/fichaArticulo.aspx?iarf=687765741232-416275192161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":25,"URL":"https:\/\/doi.org\/10.17235\/reed.2020.7217\/2020","relation":{},"ISSN":["1130-0108"],"issn-type":[{"value":"1130-0108","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}